Drug Shortage Report for BLEOMYCIN FOR INJECTION USP

Last updated on 2022-09-23 History
Report ID 162449
Drug Identification Number 02131692
Brand name BLEOMYCIN FOR INJECTION USP
Common or Proper name BLEOMYCIN FOR INJECTION USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) BLEOMYCIN
Strength(s) 15UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR INTRACAVITARY INTRA-ARTERIAL SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR INTRACAVITARY INTRA-ARTERIAL
Packaging size 15IU vial
ATC code L01DC
ATC description CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Reason for shortage Demand increase for the drug.
Anticipated start date 2022-09-22
Actual start date
Estimated end date 2022-10-31
Actual end date
Shortage status Actual shortage
Updated date 2022-09-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2022-09-23 English Compare
v10 2022-07-12 French Compare
v9 2022-07-12 English Compare
v8 2022-06-27 French Compare
v7 2022-06-27 English Compare
v6 2022-06-17 English Compare
v5 2022-06-16 French Compare
v4 2022-06-16 English Compare
v3 2022-06-16 English Compare
v2 2022-06-10 French Compare
v1 2022-06-10 English Compare

Showing 1 to 11 of 11